Risk factors in intracranial saccular aneurysms Aspects on the formation and rupture of aneurysms, and development of cerebral vasospasm

Acta Neurologica Scandinavica

Volumn 80, Issue 2, 1989, Pages 81-98

  Ostergaard J R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

cerebral vasospasm; complement activation; formation; HLA system; risk factors; rupture; saccular aneurysm; Type III collagen; warning bleeding.

Indexed keywords

COLLAGEN TYPE 3;

BRAIN VASOSPASM; HUMAN; INTRACRANIAL ANEURYSM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SACCULAR ANEURYSM; SUBARACHNOID HEMORRHAGE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMAN; HYPERTENSION; INTRACRANIAL ANEURYSM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGE; RISK FACTORS;

EID: 0024404240     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1989.tb03847.x     Document Type: Article

References (176)

1. Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage
2. Incidence, aetiology, and prognosis of primary subarachnoid hemorrhage
3. Intracranial saccular aneurysms
4. The unchanging pattern of subarachnoid hemorrhage in a community
5. Increased incidence of bleeding intracranial aneurysms in Greenlandic eskimos
6. Early aneurysm operation and outcome in two remote Scandinavian populations
7. Subarachnoid and intracerebral hemorrhage: Natural history, prognosis, and percursive factors in the Framingham Study
8. Subarachnoid hemorrhage: Epidemiology, diagnosis, management, and outcome
9. Early operation and overall outcome in aneurysmal subarachnoid hemorrhage
10. Clinical features and outcome in 1076 patients with ruptured intracranial saccular aneurysms: a prospective consecutive study
11. The pathogenesis of cerebral aneurysms
12. Intracranial aneurysms
13. Incidence of multiple intracranial aneurysms
14. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage
15. The pathology and pathogenesis of cerebral aneurysms
16. Some observations on the pathogenesis and natural history of intracranial aneurysms
17. On factors related to growth and rupture of intracranial aneurysms
18. Scanning electron microscopy of biopsy specimens of ruptured intracranial saccular aneurysms
19. Subarachnoid hemorrhage in New Zeeland: An epidemiological study
20. Epidemiology of cerebro‐vascular disease: Some unanswered questions.
21. Subarachnoid hemorrhage in Middle‐Finland: Incidence, early prognosis and indications for neurological treatment
22. Use of oral contraceptives, cigarette smoking, and risk of subarachnoid hemorrhage
23. Further analysis of mortality in oral contraceptive users
24. High‐dose estrogen‐progestagen oral contraceptives: a risk factor for aneurysmal subarachnoid hemorrhage
25. Alcohol intoxication: A risk factor for primary subarachnoid hemorrhage
26. Some patients with cerebral aneurysms are deficient in type III collagen
27. Collagen deficiency and ruptured cerebral aneurysms
28. Collagen type III deficiency in patients with rupture of intracranial saccular aneurysms
29. Cerebral aneurysms and variations in the circle of Willis
30. Association of intracranial aneurysm and arteriovenous malformation in childhood
31. Location of intracranial aneurysms associated with cerebral arteriovenous malformation: Statistical analyses
32. An association between subarachnoidal hemorrhage and influenza A infection
33. Coincidental aneurysms with tumors of pituitary
34. HLA antigens and complement types in patients with intracranial saccular aneurysms
35. Genetic markers in patients with intracranial aneurysms
36. Berry aneurysms of the circle of Willis
37. Aneurysms and anatomical variation of cerebral arteries
38. The natural history of unruptured intracranial aneurysms
39. The long‐term outcome in patients with multiple aneurysms
40. The significance of unruptured intracranial saccular aneurysms
41. Intracranial aneurysms and subarachnoid hemorrhage
42. Aneurysmal subarachnoid hemorrhage
43. Aneurysmal subarachnoid hemorrhage in Izumo City and Shimane Perfecture of Japan
44. Cerebral vasospasm after subarachnoid hemorrhage: An update
45. Intracranial arterial aneurysm – An update
46. Management of ruptured intracranial aneurysms: A review
47. Is the vasospasm following subarachnoidal hemorrhage an immunoreactive disease
48. Immunological study of late cerebral vasospasm in subarachnoid hemorrhage: Detection of immunoglobulins, C3, and fibrinogen in cerebral arterial walls by immonofluorescence method
49. Serum immunocomplexes in patients with subarachnoid hemorrhage
50. Immune complexes and complement activation following rupture of intracranial saccular aneurysms
51. Histological and morphometric observations on the reticular fibers in the arterial beds of patients with ruptured intracranial saccular aneurysms
52. On the origin of miliary aneurysms of the superficial cerebral arteries
53. Medial defects in the circle of Willis and their relation to aneurysm formation
54. The pathogenesis of non‐imflammatory cerebral aneurysms
55. Congenital aneurysms of the cerebral arteries
56. Origin, growth, and rupture of saccular aneurysms: A review
57. Etiology and pathogenesis of intracranial berry aneurysms.
58. The site, structure and frequency of intracranial aneurysms, angiomas and arteriovenous abnormalitites
59. Relation of structure to function of tissues of the wall of blood vessels
60. The reason for the shape of the distensibility curves of arteries
61. Mechanical properties of arteries
62. The roles of hyaluronic acid, collagen and elastin in the mechanical properties of connective tissue
63. Elastolytic and collage‐nolytic studies of arteries
64. Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: Immunomorphological characteristics
65. Clinical and ultrastructural heterogeneity of type IV Ehlers‐Danlos syndrome
66. What is collagen, what is not
67. Connective tissue analysis of the canine circle of Willis in hypertension
68. Patients with Ehlers‐Danlos syndrome type IV lack type III collagen
69. Ehlers‐Danlos syndrome associated with multiple intracranial aneurysms
70. Spontaneous carotid‐cavernous fistula: Ehlers‐Danlos syndrome and related conditions
71. Ehlers‐Danlos syndrome with vertebral artery aneurysm
72. Production and specificity of antibodies against the aminoterminal region in type III collagen
73. Histochemical and morphological characterization of reticular fibers
74. Comparative morphologic and histochemical studies on the collagen of vertebrate arteries
75. Some observations on reticular fibers in the tunica media of the major cerebral arteries
76. Ultrastruture of aneurysms
77. Development of intracranial aneurysms as revealed by electron microscopy
78. Subarachnoid hemorrhage in identical twins
79. Familial occurrence of intracranial aneurysms
80. Familial intracranial aneurysms and cerebral vascular anomalies
81. Familial intracranial aneurysm and infundibular widening
82. Familial intracranial aneurysms
83. Intracranial saccular aneurysms
84. Intracranial aneurysms and heredity
85. Genetic and biology of the HLA system.
86. HLA and disease 1982 – A survey
87. HLA‐DR gene and antigens in the Danish population
88. Extended HLA/complement allele haplotypes: Evidence for T/t‐like complex in man
89. Interaction of HLA molecules with non‐immunological liganda as an explanation of HLA and disease association
90. Saccular cerebral aneurysms in rats: A newly developed animal model of the disease
91. Hypertension Screening of 1 Million americans. Com‐Community hypertension evaluation clinic (CHEC) program, 1973 through 1975
92. Blood pressure in a scottish town
93. Blood pressure as a cardiovascular risk factor in a 10‐year prospective study of men and women born in 1914 and examined in 1964 and 1974 in Glostrup
94. Prevalence and management of arterial hypertension in a population sample of swedish women
95. Cooperative study of intracranial aneurysms and subarachnoid hemorrhage
96. Long‐term prognosis in surgically treated intracranial aneurysms
97. Causes of unfavorable outcome after early aneurysm operation
98. Preoperative prognostic factors for rebleeding and survial in aneurysm patients receiving antifibrinolytic therapy: Report on the cooperative aneurysm study
99. Experimental induction of cerebral aneurysms in monkeys
100. A mathematical model for the mechanises of saccular aneurysms
101. A systematic analysis of intracranial aneurysms from the autopsy file of the Presbyterian Hospital 1914 to 1956
102. Cerebral aneurysms in children
103. Intracranial arterial aneurysms in children and adolescents
104. Ruptured intracranial aneurysms in the first two decades of life
105. Intracranial aneurysms of childhood
106. Intracranial arterial aneurysms in children and adolescents
107. The size of intracranial saccular aneurysms
108. Report of a case of cerebral aneurysm in an adult developing apparently de novo
109. A long‐term follow‐up study of juvenile aneurysm patients
110. “De Novo” aneurysm
111. Systolic blood pressure, arterial rigidity, and risk of stroke: The Framingham Study
112. Ruptured intracranial aneurysm
113. Risk factors for the development and rupture of intracranial berry aneurysms
114. Risk factors related to ischemic and hemorrhagic cerebrovascular disease at atopsy: The Honolulu Heart Study
115. Saccular aneurysm of infancy and early childhood
116. Congenital saccular aneurysm in a 19‐day‐old neonate: Case report and review of the literature
117. Cerebral artery aneurysms in infancy, childhood and adolescents
118. Intracranial arterial aneurysms in childhood
119. Intracranial arterial aneurysms in infancy and childhood
120. Intracranial arterial aneurysms in early childhood
121. The necropsy demonstration of cerebral aneurysms by intra‐arterial injection
122. Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage
123. Part I. General overview.
124. Saccular intracranial aneurysms
125. Fatal rupture of intracranial aneurysms
126. Associated conditions I.
127. Experimental intracranial aneurysms in rats
128. Experimental cerebral aneurysms in rats
129. Aneurysmal subarachnoid hemorrhage and viral infection
130. Risk factors for subarachnoid hemorrhage
131. Angiographic demonstration of spasm of the intracranial arteries with special reference to saccular arterial aneurysms
132. Time course of vasospasm in man
133. Incidence and onset of vasospasm.
134. Cerebral vasospasm after subarachniod hemorrhage
135. Distribution of spasm in the intracranial arteries after subarachnoid hemorrhage
136. Ruptured intracranial aneurysm
137. Evaluation of animal models of cerebral vasospasm.
138. Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys
139. Subarachnoid hemorrhage and cerebrovascular spasm
140. Prevention of chronic experimental cerebral vasospasm with ibuprofen and high‐dose methylprednisolone
141. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall
142. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH
143. Chronic cerebral vasospasm: Effect of volume and timing of hemorrhage in a canine model
144. Erythrocytes are essential for development of cerebral vasculopathy resulting from, subarachnoid hemorrhage in cats
145. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning
146. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: A prospective study
147. Value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture
148. The value of computerized tomography in aneurysmal subarachnoid hemorrhage
149. Management of cerebral aneurysm
150. Cooperative study of intracranial aneurysms and subarachnoid hemorrhage: A long‐term prognostic study
151. Immune‐complex‐mediated biologic effects
152. Double‐decker rocket immunoelectrophoresis for direct quantitation of complement C3 spilt products with C3d specifities in plasma
153. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation
154. Reaction of the meninges to blood
155. Cerebral artery spasm
156. The angiopathy of subaracnoid hemorrhage: Angiographic and morphologic correlates
157. Glomerular immune injury in the rat: The influence of argiotension II and alfa‐adrenergic inhibitors
158. Complement dependence of hypertension in Heyman nephritis DOCA‐salt hypertensive rats
159. Response of chronic cerebral vasospasm to methylprednisolone and dexamethasone
160. Preliminary report: Effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage
161. Corticosteroids inhibit complement‐induced granulocyte aggregation
162. Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease
163. Specificity of autoantibodies in oligoclonal bands in patients with multiple sclerosis and cerebrovascular disease
164. The management of ruptured intracranial aneurysms
165. Warning signs prior to rupture of an intracranial aneurysm
166. Warning signs in intracranial aneurysms
167. Forewarnings of major subarachnoid hemorrhage
168. The warning leak in spontaneous subarachnoid hemorrhage
169. The minor leak preceding subarachnoid hemorrhage